Navigation Links
iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology
Date:4/11/2011

CHAMPAIGN, Ill., April 11, 2011 /PRNewswire/ -- iCyt Mission Technology, Inc. (iCyt), a wholly-owned subsidiary of Sony Corporation of America, today announced the introduction of its new line of 405nm-excited fluorochrome conjugated antibodies for flow cytometry. These new Brilliant Violet™ 421 products are part of the first commercial release of a novel, polymer-based fluorophore technology.

"This exciting new class of fluorescent probes will make significant contributions to the future of flow cytometry, by bringing new power and utility to the violet (405nm) laser," said Gary Durack, CEO of iCyt. "The new Brilliant Violet fluors offer dramatic improvements in brightness and signal-to-noise ratio over the current choices for the violet laser."  

In addition to being an order of magnitude brighter than traditional violet excited fluorochromes, this new dye offers greater sensitivity for resolving weakly expressed antigens, and requires less compensation for spectral overlap. Their compatibility with other popular fluorochromes and fluorescent protein combinations offers versatility that will further expand researchers' options for multi-color panels.

The initial iCyt portfolio of anti-mouse and anti-human conjugates have been optimized for use with iCyt's Eclipse™ analyzer and upcoming Synergy™ benchtop sorter, but are compatible with all major commercial flow cytometers equipped with a 405nm laser.

The new BV421 line will include an extensive antibody selection that combines consistent bright staining that is effective for surface and intracellular antigens, with simple, ready-to-use, low volume test size.  The new probes are fixation stable and compatible with standard staining buffers.  

iCyt intends to continually expand its new line of BV reagents, which complement its already broad portfolio of mouse and human monoclonal antibodies tailored for use in cell biology, immunology, cancer research, and stem cell research.

"iCyt and Sony are committed to leading the way in bringing innovative, new instrument and reagent technology combinations to market, that maximize performance and value for our customers," added Durack.

About iCyt:

iCyt supplies advanced flow cytometry analysis and sorting technology for use in life science research. Its products are marketed to private and public research institutions, pharmaceutical and biotechnology companies, and large medical centers. iCyt has received significant industry recognition for its line of multi-channel, high-speed cell sorting products. iCyt, a wholly owned subsidiary of Sony Corporation of America, is headquartered in Champaign, Illinois. For more information, visit www.i-cyt.com.

Synergy and Eclipse are trademarks of iCyt Mission Technology, Inc. Brilliant Violet and Brilliant Violet 421 are trademarks of Sirigen Ltd.


'/>"/>
SOURCE iCyt Mission Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alcoa Unveils Partnership for Carbon Capture Technology Pilot Test Designed to Turn Emissions Into Beneficial Commercial Products
2. Generex Unveils Strategic Development Plan
3. Sigma-Aldrich Unveils Dynamic New Web Presence
4. NABP Unveils Relaunch of AWARErx.org
5. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
6. Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services
7. New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services
8. Troy Healthcare, LLC Acquires Stopain® Brand; Unveils New Pain Relieving Gel Set to Hit Stores in Early 2011
9. Pepex™ Unveils Development of First All-In-One Blood Glucose Meter
10. eTransX Unveils Latest Version of Its eTX HEMI
11. ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... PLAD, Inc. (OTC Pink: PLAD) is pleased to announce ... company targets, are adding key personnel to their national ... United States Patent and Trademark Office for the characters ... of PLAD, Inc.  In January, PLAD established their presence ... with two new customers, Cumberland Goodwill EMS and Meadville ...
(Date:2/11/2016)... 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , ... an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the ...
Breaking Medicine Technology:
(Date:2/11/2016)... City, FL (PRWEB) , ... February 11, 2016 ... ... announced the commencement of a master charity program created to assist the people ... 60 days, working closely with nonprofit organizations and community leaders. Their hope is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance Group, serving ... introduces a new charity campaign to raise funds for Ronald McDonald House Charities. ... https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally renowned nonprofit ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce ... South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge ... of their homes, offices or at the practices’ local office. It is also one ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for American ... and wellness best practices in the past couple of decades, and food manufacturers ... Heart Month, which acts as an exceptional opportunity to revise food labels and ...
(Date:2/10/2016)... ... 10, 2016 , ... President Obama’s budget proposal yesterday enables ... medical services via telehealth, estimated to generate more than $160 million in savings ... many years. Although there is more to be done, this represents an ...
Breaking Medicine News(10 mins):